Latest Leverage News

Cleo Diagnostics has expanded its ovarian cancer biomarker panel from five to eight markers, enhancing test reliability and gearing up for FDA submission. A manufacturing deal is imminent, setting the stage for commercial rollout.

Enlitic has secured a $1.5 million contract to migrate over 71 million clinical files for Penn Medicine Doylestown Health, reinforcing its foothold in the US healthcare IT sector.

Synlait confirms the imminent sale of its North Island assets to Abbott for NZ$307 million, aiming to reset its balance sheet amid a challenging half-year result. The company unveils a recovery roadmap focused on stabilising and scaling its core operations.

Synlait Milk Limited has reported a significant half-year loss driven by manufacturing setbacks and market pressures, alongside a strategic recovery roadmap focused on asset sales and operational overhaul.

Noronex Limited announces the resignation of CEO Victor Rajasooriar, who will transition to Wiluna Mining Corporation, while the Board steps in to manage ongoing exploration projects in Botswana and Namibia.

Aldoro Resources has finalised the sale of its Wyemandoo Project to Coppermoly, receiving A$100,000 and redirecting its efforts towards its flagship Kameelburg project.

Renascor Resources reports significant cobalt and copper mineralisation from its recent Bulloo Creek drilling program, while advancing exploration across South Australia’s Olary, Marree, Wooltana, and Tumby Bay projects.

AdAlta Limited has been granted a key Canadian patent for its anti-fibrotic drug AD-214, completing its composition of matter protection across all major commercial markets. This milestone strengthens the company’s intellectual property portfolio and underpins its commercial strategy for AD-214.

Klevo Rewards’ subsidiary Fly Wallet has gained multi-jurisdictional certification, paving the way for its corporate card programs across 18 international markets.

Advanced Energy Minerals is ramping up production capacity at its Quebec plant, leveraging patented low-cost technology and renewable energy to meet booming global demand for high purity alumina.

CLINUVEL Pharmaceuticals reports record first-half profits and confirms CEO Philippe Wolgen’s leadership through a pivotal growth phase, prioritising its vitiligo program and Nasdaq ambitions.

Diatreme Resources has reported a significant boost in mineral recoveries and production forecasts for its Cyclone Project in Western Australia, driven by advanced metallurgical testwork and flowsheet optimisation.